Last reviewed · How we verify
Adenocarcinoma of the ovary
Approved treatments
- Cyclophosphamid · Zhejiang University
- Cytoxan (Lyophilized) · Baxter
Cyclophosphamide cross-links tumor cell DNA and interferes with malignant cell growth through active alkylating metabolites. - Cytoxan (Lyophilized) · Baxter
Cytoxan works by interfering with the DNA replication process in rapidly dividing cancer cells.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Adenocarcinoma of the ovary patent landscape — cliff calendar, originator estates, attackable patents
- Adenocarcinoma of the ovary treatment landscape brief
- Adenocarcinoma of the ovary treatment updates RSS
Frequently asked questions about Adenocarcinoma of the ovary
What drugs treat Adenocarcinoma of the ovary?
Tracked treatments include Cyclophosphamid, Cytoxan (Lyophilized).
What is the treatment for Adenocarcinoma of the ovary?
Standard treatment for Adenocarcinoma of the ovary includes Cyclophosphamid, Cytoxan (Lyophilized). See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Adenocarcinoma of the ovary patent cliff · Adenocarcinoma of the ovary CI report
- Treatment: Cyclophosphamid · Zhejiang University
- Treatment: Cytoxan (Lyophilized) · Baxter
- Treatment: Cytoxan (Lyophilized) · Baxter
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing